Benchmark Capital Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$3.41M Buy
212,250
+300
+0.1% +$4.75K 3.4% 5
2018
Q3
$3.16M Sell
211,950
-5,300
-2% -$77.3K 2.38% 9
2018
Q2
$3.05M Sell
217,250
-5,300
-2% -$70.2K 2.31% 10
2018
Q1
$2.89M Sell
222,550
-6,800
-3% -$87K 2.29% 12
2017
Q4
$3.16M Sell
229,350
-2,500
-1% -$33.8K 2.47% 10
2017
Q3
$3.04M Sell
231,850
-7,700
-3% -$99.2K 2.36% 9
2017
Q2
$3.08M Buy
239,550
+2,450
+1% +$32.6K 2.43% 7
2017
Q1
$3.06M Buy
237,100
+41,100
+21% +$526K 2.41% 8
2016
Q4
$2.41M Buy
196,000
+16,300
+9% +$211K 2% 15
2016
Q3
$2.65M Sell
179,700
-1,200
-0.7% -$18.2K 2% 12
2016
Q2
$2.75M Buy
180,900
+1,700
+0.9% +$24.1K 2.24% 10
2016
Q1
$2.33M Sell
179,200
-16,500
-8% -$188K 2.04% 15
2015
Q4
$2.25M Buy
195,700
+2,000
+1% +$22.8K 1.91% 17
2015
Q3
$2.14M Buy
193,700
+176,200
+1,007% +$2.19M 1.75% 15
2015
Q2
$229K Buy
+17,500
New +$244K 0.16% 101

Other funds holding MPT

Benchmark Capital Advisors's MPT Position: Q4 2018 in Review

Benchmark Capital Advisors increased its Medical Properties Trust (MPT) stake by 0.14% in Q4 2018, buying an estimated $4.75K and bringing the position to 212,250 shares worth $3.41M. The position accounts for 3.4% of the portfolio, ranked #5.

Benchmark Capital Advisors first reported a position in MPT in Q2 2015 and has held it in 15 quarters since. 419 funds tracked by Wall St. Rank hold MPT as of Q4 2018.

  • Benchmark Capital Advisors held 212,250 shares of Medical Properties Trust worth $3.41M as of Q4 2018.
  • Benchmark Capital Advisors bought 300 Medical Properties Trust shares in Q4 2018, an estimated $4.75K.
  • Medical Properties Trust made up 3.4% of Benchmark Capital Advisors's portfolio in Q4 2018, its #5 holding.
  • Benchmark Capital Advisors first reported a position in Medical Properties Trust in Q2 2015 and has held it in 15 quarters since.
  • 419 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2018.

Based on Benchmark Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.